chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Fatigue, Illness, Malaise
Clinical narrative: tired all the time; vision was blurred; migraine; want to lie down/ he is not same after getting vaccine; doesn't not have energy; sick for 3 days; diarrhea; vomiting; feverish; totally totally whole body was achy; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ASTHENIA (doesn't not have energy) and ILLNESS (sick for 3 days) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, LISINOPRIL, GLIMEPIRIDE, ROSUVASTATIN CALCIUM (CRESTOR), PIOGLITAZONE HYDROCHLORIDE (ACTOS), CANAGLIFLOZIN (INVOKANA [CANAGLIFLOZIN]), RIVAROXABAN (XARELTO), METOPROLOL TARTRATE and AMIODARONE for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ASTHENIA (doesn't not have energy), ILLNESS (sick for 3 days), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (feverish) and MYALGIA (totally totally whole body was achy). On an unknown date, the patient experienced FATIGUE (tired all the time). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and CYANOCOBALAMIN (B 12) for Loss of energy, at an unspecified dose and frequency. On 02-Mar-2021, VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ILLNESS (sick for 3 days), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (feverish) and MYALGIA (totally totally whole body was achy) had resolved. At the time of the report, ASTHENIA (doesn't not have energy) and FATIGUE (tired all the time) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-076282 (Patient Link).
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine, Myalgia, Pyrexia, Vision blurred, Vomiting
Clinical narrative: tired all the time; vision was blurred; migraine; want to lie down/ he is not same after getting vaccine; doesn't not have energy; sick for 3 days; diarrhea; vomiting; feverish; totally totally whole body was achy; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ASTHENIA (doesn't not have energy) and ILLNESS (sick for 3 days) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METFORMIN, LISINOPRIL, GLIMEPIRIDE, ROSUVASTATIN CALCIUM (CRESTOR), PIOGLITAZONE HYDROCHLORIDE (ACTOS), CANAGLIFLOZIN (INVOKANA [CANAGLIFLOZIN]), RIVAROXABAN (XARELTO), METOPROLOL TARTRATE and AMIODARONE for an unknown indication.   On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Feb-2021, the patient experienced VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ASTHENIA (doesn't not have energy), ILLNESS (sick for 3 days), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (feverish) and MYALGIA (totally totally whole body was achy). On an unknown date, the patient experienced FATIGUE (tired all the time). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency and CYANOCOBALAMIN (B 12) for Loss of energy, at an unspecified dose and frequency. On 02-Mar-2021, VISION BLURRED (vision was blurred), MIGRAINE (migraine), MALAISE (want to lie down/ he is not same after getting vaccine), ILLNESS (sick for 3 days), DIARRHOEA (diarrhea), VOMITING (vomiting), PYREXIA (feverish) and MYALGIA (totally totally whole body was achy) had resolved. At the time of the report, ASTHENIA (doesn't not have energy) and FATIGUE (tired all the time) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       This case was linked to MOD-2021-076282 (Patient Link).
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Hypersensitivity, Nasal congestion, Pruritus, Rash, Swelling face
Clinical narrative: skin in my arms have a rash/ my face is also affected now; areas in my arms are very itchy/it weeps and expands more; allergies have gotten worse; puffiness in cheeks; congestion; This spontaneous case was reported by a consumer and describes the occurrence of RASH (skin in my arms have a rash/ my face is also affected now), SWELLING FACE (puffiness in cheeks), NASAL CONGESTION (congestion), PRURITUS (areas in my arms are very itchy/it weeps and expands more) and HYPERSENSITIVITY (allergies have gotten worse) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concomitant products included CALCIUM and IBUPROFEN for an unknown indication.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced SWELLING FACE (puffiness in cheeks) and NASAL CONGESTION (congestion). On an unknown date, the patient experienced RASH (skin in my arms have a rash/ my face is also affected now), PRURITUS (areas in my arms are very itchy/it weeps and expands more) and HYPERSENSITIVITY (allergies have gotten worse). At the time of the report, RASH (skin in my arms have a rash/ my face is also affected now), SWELLING FACE (puffiness in cheeks), NASAL CONGESTION (congestion), PRURITUS (areas in my arms are very itchy/it weeps and expands more) and HYPERSENSITIVITY (allergies have gotten worse) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The treatment information was unknown.   This case was linked to MOD-2021-109926 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Follow up received on 6-MAY-2021 and added 2nd dose details. added concomitant medication. added new events.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: vaccination site itching; swollen below the injection site; circle with pinpoint red spots below the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (vaccination site itching), VACCINATION SITE SWELLING (swollen below the injection site) and VACCINATION SITE ERYTHEMA (circle with pinpoint red spots below the injection site) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (vaccination site itching), VACCINATION SITE SWELLING (swollen below the injection site) and VACCINATION SITE ERYTHEMA (circle with pinpoint red spots below the injection site). At the time of the report, VACCINATION SITE PRURITUS (vaccination site itching) and VACCINATION SITE SWELLING (swollen below the injection site) outcome was unknown and VACCINATION SITE ERYTHEMA (circle with pinpoint red spots below the injection site) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. No treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Therapeutic response unexpected
Clinical narrative: she had issue with migraine and that issue went away; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (she had issue with migraine and that issue went away) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (she had issue with migraine and that issue went away). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (she had issue with migraine and that issue went away) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant information was reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-076401 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076401:Case for patient's friend with MI referecne number MOD21-075201 (Same reporter)
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Vaccination site pain
Clinical narrative: injection site sore/injection site is tender; fatigue; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site sore/injection site is tender) and FATIGUE (fatigue) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced VACCINATION SITE PAIN (injection site sore/injection site is tender) and FATIGUE (fatigue). At the time of the report, VACCINATION SITE PAIN (injection site sore/injection site is tender) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-076760 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076760:Case deleted
Sex: F
Vaccine: COVID19
Symptoms: Headache, Muscle spasms
Clinical narrative: leg cramps; headache; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (leg cramps) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 2 dosage form. On 13-Apr-2021, the patient experienced MUSCLE SPASMS (leg cramps) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date for Headache, at a dose of UNK dosage form. At the time of the report, MUSCLE SPASMS (leg cramps) and HEADACHE (headache) outcome was unknown.            Reporter provided only limited adverse event data as the agent could not provide any medical advice.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site discolouration, Vaccination site erythema, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Swollen arm with redness and black and blue at the center; Injection site hot to touch; Swollen arm with redness and black and blue at the center; Swollen arm with redness and black and blue at the center; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLORATION (Swollen arm with redness and black and blue at the center), VACCINATION SITE WARMTH (Injection site hot to touch), VACCINATION SITE ERYTHEMA (Swollen arm with redness and black and blue at the center) and VACCINATION SITE SWELLING (Swollen arm with redness and black and blue at the center) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE DISCOLORATION (Swollen arm with redness and black and blue at the center), VACCINATION SITE WARMTH (Injection site hot to touch), VACCINATION SITE ERYTHEMA (Swollen arm with redness and black and blue at the center) and VACCINATION SITE SWELLING (Swollen arm with redness and black and blue at the center). The patient was treated with ACRIVASTINE (BENADRYL ALLERGY RELIEF) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE DISCOLORATION (Swollen arm with redness and black and blue at the center), VACCINATION SITE WARMTH (Injection site hot to touch), VACCINATION SITE ERYTHEMA (Swollen arm with redness and black and blue at the center) and VACCINATION SITE SWELLING (Swollen arm with redness and black and blue at the center) outcome was unknown.            No concomitant medication information was provided.  Patient suggested to take oral steroid.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) was resolving. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications information provided.  No treatment medication information reported.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Dizziness; Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and DIZZINESS (Dizziness) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A2A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced VERTIGO (Vertigo). On 13-Mar-2021, the patient experienced DIZZINESS (Dizziness). On 13-Mar-2021, VERTIGO (Vertigo) had resolved. At the time of the report, DIZZINESS (Dizziness) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided. treatment medication includes motion sickness medication. patient states she is feeling okay.   This case was linked to US-MODERNATX, INC.-MOD-2021-076267 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Updated event outcome and treatment medication.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: body aches; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040b21a) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced MYALGIA (body aches). At the time of the report, MYALGIA (body aches) had not resolved. Not Provided          No concomitant medications were reported. No treatment medication was reported.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was Not applicable.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Paraesthesia, Rash, Somnolence, Tinnitus
Clinical narrative: Rash on arm; Sleepy; Light tingle in right fingers / arm; Tip of tongue felt numb; High pitched sound; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (Sleepy), PARAESTHESIA (Light tingle in right fingers / arm), HYPOAESTHESIA ORAL (Tip of tongue felt numb), TINNITUS (High pitched sound) and RASH (Rash on arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029M21A) for COVID-19 vaccination.     No medical history information was reported.     On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, the patient experienced SOMNOLENCE (Sleepy), PARAESTHESIA (Light tingle in right fingers / arm), HYPOAESTHESIA ORAL (Tip of tongue felt numb) and TINNITUS (High pitched sound). On 14-Mar-2021, the patient experienced RASH (Rash on arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE (BENADRYL ITCH STOPPING CREAM) ongoing since an unknown date at an unspecified dose and frequency. On 06-Mar-2021, PARAESTHESIA (Light tingle in right fingers / arm) and HYPOAESTHESIA ORAL (Tip of tongue felt numb) had resolved. On 07-Mar-2021, SOMNOLENCE (Sleepy) had resolved. On 19-Mar-2021, RASH (Rash on arm) had resolved. At the time of the report, TINNITUS (High pitched sound) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information provided.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: injection site pain after first dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (injection site pain after first dose) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical history information was reported.     On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, the patient experienced VACCINATION SITE PAIN (injection site pain after first dose). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 23-Feb-2021, VACCINATION SITE PAIN (injection site pain after first dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-076245 (Patient Link).
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Nausea, Pyrexia, Vaccination site movement impairment
Clinical narrative: couldn't lift her arm; achy joints; chills; nausea; fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't lift her arm), ARTHRALGIA (achy joints), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't lift her arm), ARTHRALGIA (achy joints), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever). On 11-Apr-2021, VACCINATION SITE MOVEMENT IMPAIRMENT (couldn't lift her arm), ARTHRALGIA (achy joints), CHILLS (chills), NAUSEA (nausea) and PYREXIA (fever) had resolved.            No concomitant medications were provided by the reporter. Reportedly the patient is very thin.  Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-074747 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074747:Mother's case
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Dizziness, Fatigue, Headache, Pyrexia
Clinical narrative: dizziness; headache; tiredness; slight fever; stomach ache; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), DIZZINESS (dizziness), VACCINATION SITE PAIN (soreness at injection site), HEADACHE (headache) and FATIGUE (tiredness) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site). On 13-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), HEADACHE (headache), FATIGUE (tiredness) and PYREXIA (slight fever). On 14-Apr-2021, the patient experienced DIZZINESS (dizziness). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), DIZZINESS (dizziness), VACCINATION SITE PAIN (soreness at injection site), HEADACHE (headache), FATIGUE (tiredness) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.  No treatment information was provided.   This case was linked to MODERNATX, INC.-MOD-2021-107185 (E2B Linked Report); Sender's Comments:  MODERNATX, INC.-MOD-2021-107185:
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: dizziness; headache; tiredness; slight fever; stomach ache; soreness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach ache), DIZZINESS (dizziness), VACCINATION SITE PAIN (soreness at injection site), HEADACHE (headache) and FATIGUE (tiredness) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced VACCINATION SITE PAIN (soreness at injection site). On 13-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach ache), HEADACHE (headache), FATIGUE (tiredness) and PYREXIA (slight fever). On 14-Apr-2021, the patient experienced DIZZINESS (dizziness). At the time of the report, ABDOMINAL PAIN UPPER (stomach ache), DIZZINESS (dizziness), VACCINATION SITE PAIN (soreness at injection site), HEADACHE (headache), FATIGUE (tiredness) and PYREXIA (slight fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication reported.  No treatment information was provided.   This case was linked to MODERNATX, INC.-MOD-2021-107185 (E2B Linked Report); Sender's Comments:  MODERNATX, INC.-MOD-2021-107185:
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling
Clinical narrative: Itches; Left arm swelling; Redness; Injection site is hurting; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Apr-2021 and was forwarded to Moderna on 14-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (Itches), INJECTION SITE SWELLING (Left arm swelling), INJECTION SITE ERYTHEMA (Redness) and INJECTION SITE PAIN (Injection site is hurting) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced INJECTION SITE PRURITUS (Itches), INJECTION SITE SWELLING (Left arm swelling), INJECTION SITE ERYTHEMA (Redness) and INJECTION SITE PAIN (Injection site is hurting). At the time of the report, INJECTION SITE PRURITUS (Itches), INJECTION SITE SWELLING (Left arm swelling), INJECTION SITE ERYTHEMA (Redness) and INJECTION SITE PAIN (Injection site is hurting) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not Applicable
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Presyncope, Vomiting
Clinical narrative: Can not move her arm; vomiting; About to pass out; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (About to pass out), MOBILITY DECREASED (Can not move her arm) and VOMITING (vomiting) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No medical history information was provided by the reporter.     On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PRESYNCOPE (About to pass out). On 02-Apr-2021, the patient experienced MOBILITY DECREASED (Can not move her arm) and VOMITING (vomiting). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) ongoing since an unknown date at an unspecified dose and frequency. On 01-Apr-2021, PRESYNCOPE (About to pass out) had resolved. On 03-Apr-2021, VOMITING (vomiting) had resolved. At the time of the report, MOBILITY DECREASED (Can not move her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Pain in the body after the first dose; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain in the body after the first dose) and PYREXIA (Fever) in a 24-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A1A and 020B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Mar-2021, the patient experienced PAIN (Pain in the body after the first dose) and PYREXIA (Fever). At the time of the report, PAIN (Pain in the body after the first dose) and PYREXIA (Fever) had resolved.            Patient stated that he did not have any side effects after 2nd dose and feeling fine now.  Concomitant medications were not reported.  Treatment medications were not provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Feeling drunk, Pain in extremity, Somnolence, Vertigo
Clinical narrative: vertigo; Felt Drunk; Groggy; Tired; Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo), FEELING DRUNK (Felt Drunk), SOMNOLENCE (Groggy), PAIN IN EXTREMITY (Sore arm) and FATIGUE (Tired) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021321A and 036A2A) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Sore arm). On an unknown date, the patient experienced VERTIGO (vertigo), FEELING DRUNK (Felt Drunk), SOMNOLENCE (Groggy) and FATIGUE (Tired). On 04-Apr-2021, PAIN IN EXTREMITY (Sore arm) had resolved. At the time of the report, VERTIGO (vertigo), FEELING DRUNK (Felt Drunk), SOMNOLENCE (Groggy) and FATIGUE (Tired) outcome was unknown.            Concomitant medication information was not reported.  Treatment medication information was not reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-076256.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever 100.5; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever 100.5) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever 100.5). At the time of the report, PYREXIA (fever 100.5) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.  No treatment medication information was given.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: Severe headache; throbbing arm/Severe Arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (throbbing arm/Severe Arm pain) and HEADACHE (Severe headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was provided.     On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced PAIN IN EXTREMITY (throbbing arm/Severe Arm pain). On 05-Apr-2021, the patient experienced HEADACHE (Severe headache). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. On 10-Apr-2021, PAIN IN EXTREMITY (throbbing arm/Severe Arm pain) had resolved. At the time of the report, HEADACHE (Severe headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Ear pain, Headache, Ocular hyperaemia
Clinical narrative: diagnosed with sinus infection; side effects of headache, ear ache and red eye are still present at this time; side effects of headache, ear ache and red eye are still present at this time; side effects of headache, ear ache and red eye are still present at this time; headaches on the left side moves down to her left shoulder; headaches on the left side of head / headaches on the left side of head; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (side effects of headache, ear ache and red eye are still present at this time), OCULAR HYPERAEMIA (side effects of headache, ear ache and red eye are still present at this time), SINUSITIS (diagnosed with sinus infection), HEADACHE (side effects of headache, ear ache and red eye are still present at this time) and ARTHRALGIA (headaches on the left side moves down to her left shoulder) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 07-Apr-2021, the patient experienced ARTHRALGIA (headaches on the left side moves down to her left shoulder) and HEADACHE (headaches on the left side of head / headaches on the left side of head). On 15-Apr-2021, the patient experienced EAR PAIN (side effects of headache, ear ache and red eye are still present at this time) and OCULAR HYPERAEMIA (side effects of headache, ear ache and red eye are still present at this time). On an unknown date, the patient experienced SINUSITIS (diagnosed with sinus infection) and HEADACHE (side effects of headache, ear ache and red eye are still present at this time). At the time of the report, EAR PAIN (side effects of headache, ear ache and red eye are still present at this time), OCULAR HYPERAEMIA (side effects of headache, ear ache and red eye are still present at this time), SINUSITIS (diagnosed with sinus infection) and HEADACHE (side effects of headache, ear ache and red eye are still present at this time) had not resolved and ARTHRALGIA (headaches on the left side moves down to her left shoulder) and HEADACHE (headaches on the left side of head / headaches on the left side of head) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, COVID-19: negative unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient was diagnosed with a sinus infection and given medication for treatment.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: No specific follow-up information recorded.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Sinusitis
Clinical narrative: diagnosed with sinus infection; side effects of headache, ear ache and red eye are still present at this time; side effects of headache, ear ache and red eye are still present at this time; side effects of headache, ear ache and red eye are still present at this time; headaches on the left side moves down to her left shoulder; headaches on the left side of head / headaches on the left side of head; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (side effects of headache, ear ache and red eye are still present at this time), OCULAR HYPERAEMIA (side effects of headache, ear ache and red eye are still present at this time), SINUSITIS (diagnosed with sinus infection), HEADACHE (side effects of headache, ear ache and red eye are still present at this time) and ARTHRALGIA (headaches on the left side moves down to her left shoulder) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 07-Apr-2021, the patient experienced ARTHRALGIA (headaches on the left side moves down to her left shoulder) and HEADACHE (headaches on the left side of head / headaches on the left side of head). On 15-Apr-2021, the patient experienced EAR PAIN (side effects of headache, ear ache and red eye are still present at this time) and OCULAR HYPERAEMIA (side effects of headache, ear ache and red eye are still present at this time). On an unknown date, the patient experienced SINUSITIS (diagnosed with sinus infection) and HEADACHE (side effects of headache, ear ache and red eye are still present at this time). At the time of the report, EAR PAIN (side effects of headache, ear ache and red eye are still present at this time), OCULAR HYPERAEMIA (side effects of headache, ear ache and red eye are still present at this time), SINUSITIS (diagnosed with sinus infection) and HEADACHE (side effects of headache, ear ache and red eye are still present at this time) had not resolved and ARTHRALGIA (headaches on the left side moves down to her left shoulder) and HEADACHE (headaches on the left side of head / headaches on the left side of head) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Apr-2021, COVID-19: negative unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Patient was diagnosed with a sinus infection and given medication for treatment.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: No specific follow-up information recorded.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Contusion, Noninfective gingivitis
Clinical narrative: Her gums a little inflamed; 3 bruises on her body: 2 on her left leg below the knee, and 1 on her right arm; This spontaneous case was reported by a consumer and describes the occurrence of NONINFECTIVE GINGIVITIS (Her gums a little inflamed) and CONTUSION (3 bruises on her body: 2 on her left leg below the knee, and 1 on her right arm) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     The patient's past medical history included Anemia (Low hemoglobin). Concurrent medical conditions included Iodine allergy.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Apr-2021, the patient experienced NONINFECTIVE GINGIVITIS (Her gums a little inflamed) and CONTUSION (3 bruises on her body: 2 on her left leg below the knee, and 1 on her right arm). At the time of the report, NONINFECTIVE GINGIVITIS (Her gums a little inflamed) and CONTUSION (3 bruises on her body: 2 on her left leg below the knee, and 1 on her right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used included birth control pills. No treatment medication was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling cold, Headache, Hyperhidrosis, Injection site erythema
Clinical narrative: Pain; Redness; Swelling; Felt cold for half of the night; Rest of the night she had sweating; Headache; Muscle pains; Injection site appears bright red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), ERYTHEMA (Redness), SWELLING (Swelling), FEELING COLD (Felt cold for half of the night) and HYPERHIDROSIS (Rest of the night she had sweating) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), CITALOPRAM, FENOFIBRIC ACID and COLESEVELAM HCL for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain), ERYTHEMA (Redness), SWELLING (Swelling), FEELING COLD (Felt cold for half of the night), HYPERHIDROSIS (Rest of the night she had sweating), HEADACHE (Headache), MYALGIA (Muscle pains) and INJECTION SITE ERYTHEMA (Injection site appears bright red). At the time of the report, PAIN (Pain), ERYTHEMA (Redness), SWELLING (Swelling), FEELING COLD (Felt cold for half of the night), HYPERHIDROSIS (Rest of the night she had sweating), HEADACHE (Headache), MYALGIA (Muscle pains) and INJECTION SITE ERYTHEMA (Injection site appears bright red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Pain, Swelling
Clinical narrative: Pain; Redness; Swelling; Felt cold for half of the night; Rest of the night she had sweating; Headache; Muscle pains; Injection site appears bright red; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Pain), ERYTHEMA (Redness), SWELLING (Swelling), FEELING COLD (Felt cold for half of the night) and HYPERHIDROSIS (Rest of the night she had sweating) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID), CITALOPRAM, FENOFIBRIC ACID and COLESEVELAM HCL for an unknown indication.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Pain), ERYTHEMA (Redness), SWELLING (Swelling), FEELING COLD (Felt cold for half of the night), HYPERHIDROSIS (Rest of the night she had sweating), HEADACHE (Headache), MYALGIA (Muscle pains) and INJECTION SITE ERYTHEMA (Injection site appears bright red). At the time of the report, PAIN (Pain), ERYTHEMA (Redness), SWELLING (Swelling), FEELING COLD (Felt cold for half of the night), HYPERHIDROSIS (Rest of the night she had sweating), HEADACHE (Headache), MYALGIA (Muscle pains) and INJECTION SITE ERYTHEMA (Injection site appears bright red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous
Clinical narrative: Rash breakout with red bumps all over body, mostly under arms and things; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (Rash breakout with red bumps all over body, mostly under arms and things) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Depression. Concomitant products included QUETIAPINE FUMARATE (SEROQUEL) for Antidepressant therapy.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Apr-2021, the patient experienced RASH ERYTHEMATOUS (Rash breakout with red bumps all over body, mostly under arms and things). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and CORTISONE at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (Rash breakout with red bumps all over body, mostly under arms and things) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, SARS-CoV-2 test
Clinical narrative: Feeling sick; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Feeling sick) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014N20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced MALAISE (Feeling sick). At the time of the report, MALAISE (Feeling sick) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant and treatment medications were reported. Patient was tested positive for covid-19 and kept quarantine until 29-MAR-2021. Patient was scheduled for her second dose on 19 APR 2021.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Received his first dose on 5Feb2021 and then returned today for second dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received his first dose on 5Feb2021 and then returned today for second dose) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received his first dose on 5Feb2021 and then returned today for second dose). On 05-Feb-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received his first dose on 5Feb2021 and then returned today for second dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing was delayed on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided. Treatment medications were unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Injection site reactions like itching; Tenderness in the right arm; Redness in the right arm; Swelling in the right arm; Injection site reactions like pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site reactions like itching), VACCINATION SITE PAIN (Injection site reactions like pain), VACCINATION SITE PAIN (Tenderness in the right arm), VACCINATION SITE ERYTHEMA (Redness in the right arm) and VACCINATION SITE SWELLING (Swelling in the right arm) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Apr-2021, the patient experienced VACCINATION SITE PAIN (Injection site reactions like pain). On 06-Apr-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness in the right arm) and VACCINATION SITE SWELLING (Swelling in the right arm). On 13-Apr-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site reactions like itching) and VACCINATION SITE PAIN (Tenderness in the right arm). On 05-Apr-2021, VACCINATION SITE PAIN (Injection site reactions like pain) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Injection site reactions like itching), VACCINATION SITE ERYTHEMA (Redness in the right arm) and VACCINATION SITE SWELLING (Swelling in the right arm) had not resolved and VACCINATION SITE PAIN (Tenderness in the right arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. Treatment medications were unknown.